(220 days)
The purpose of this Guideline is to provide clarity and guidance regarding the use of a digital pathology system which utilizes artificial intelligence (AI)-based image analysis algorithms. It describes the intended use of the system and covers relevant considerations related to its functionality, setup, and use in a pathology laboratory environment. This includes the following:
- Clear indications for use, including the patient population, sample type, purpose of the analysis, and interpretation of the results.
- Description of the AI algorithms used, including their validation and performance characteristics.
- Guidelines for system setup and configuration, including hardware and software requirements, calibration procedures, and quality control measures.
- Recommendations for training and competency assessment of users.
- Instructions for data management and archiving.
- Considerations for potential limitations and risks associated with the use of the system.
- Reporting of results, including integration with laboratory information systems.
- Post-market surveillance and system updates.
- Adherence to relevant regulatory requirements and standards.
By following this Guideline, pathology laboratories can ensure the safe and effective use of AI-based image analysis in digital pathology, contributing to improved diagnostic accuracy and patient care.
A compact USB-C hub designed to expand connectivity options, featuring multiple ports including USB-A, HDMI, SD card reader, and a passthrough charging port, ideal for laptops with limited ports.
The provided FDA clearance letter for Terumo's Hypodermic Needle (K243309) does not describe a study involving acceptance criteria for device performance in the context of an AI/ML or diagnostic imaging device. Instead, this document is a 510(k) submission for a medical device (a hypodermic needle) that demonstrates substantial equivalence to a predicate device.
The "acceptance criteria" and "study that proves the device meets the acceptance criteria" in this document refer to performance verification tests for a physical medical device (hypodermic needle), rather than the kind of AI/ML or diagnostic performance evaluation described in the prompt's request.
Therefore, the requested information (table of acceptance criteria and device performance for AI/ML, sample sizes for test/training sets, expert qualifications, ground truth establishment, MRMC studies, etc.) is not applicable to this document.
The document primarily focuses on:
- Substantial Equivalence: Demonstrating that the new needle is as safe and effective as a previously cleared predicate device, despite a minor change (increased inner diameter/thin wall vs. regular wall).
- Non-Clinical Testing: Citing compliance with various ISO standards for hypodermic needles, biocompatibility, sterilization, and shelf-life, which are the "acceptance criteria" for this type of device.
- No Clinical Testing: Explicitly stating that clinical test data was not included because the changes were supported by non-clinical performance verification.
If this were an AI/ML or diagnostic device, the document would contain sections detailing sensitivity, specificity, AUC, human reader studies, etc., none of which are present here.
§ 880.5570 Hypodermic single lumen needle.
(a)
Identification. A hypodermic single lumen needle is a device intended to inject fluids into, or withdraw fluids from, parts of the body below the surface of the skin. The device consists of a metal tube that is sharpened at one end and at the other end joined to a female connector (hub) designed to mate with a male connector (nozzle) of a piston syringe or an intravascular administration set.(b)
Classification. Class II (performance standards).